The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure.

1.
Fitzsimons Redevelopment Authority Announces Second Phase of Strategic Refocus With $8 Million
Expansion to Bioscience Park Center with 37,000‐Square‐Foot Accelerator Facility
The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50%
with an $8 million, 37,000‐square‐foot accelerator structure. The new accelerator space will be leased to
existing tenants graduating from the incubator and other companies in the modest growth stage.
Aurora, CO, December 12, 2011 ‐ In furtherance of its renewed commitment to support the growth of early‐
stage Colorado bioscience companies, especially those developing technologies from Colorado's research
institutions, Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center building (BPC)
with an $8 million, 37,000‐square‐foot accelerator facility, increasing the BPC in excess of 50 percent. The
announcement is made by Denise Brown, FRA Interim Executive Director, who says, "The new accelerator
space will be leased to companies in the modest growth stage. We have a number of companies in the BPC
incubator ready to make this advancement in addition to interest from other companies, both in‐state and
out‐of‐state, as well."
The FRA Board of Directors has been working with FRA staff, FRA's real estate development partner Forest City
Science + Technology Group, consultants and lenders for the past several months to finalize this expansion.
Based on the team's recommendation, the three‐story accelerator will be built to the west of the current
building with a new parking lot located to the north of BPC. Ground broke in October and construction has
been progressing since, with completion expected by June, as recently reported in the Aurora Sentinel,
http://www.aurorasentinel.com/email_push/news/article_95c4538e‐1792‐11e1‐a67e‐001cc4c03286.html.
According to Brown, expansion of the BPC structure with the accelerator has these advantages:
 FRA's BPC site is adjacent to the University research facilities.
 Tenants will have easy access to the amenities already in place at BCP, thereby eliminating the need to replicate
conference rooms and other amenities in the expansion.
 The expansion is capable of housing highly technical life science research and development activities
 The expansion connecting to an existing building creates cost savings for tenants as compared to stand‐alone
new construction
‐More‐

2. Page 2
Last month, as the first phase of its strategic refocus, FRA announced the restructure of its board to include
bioscience industry leadership. Those additions include Donald M. Elliman, Jr., Executive Director of the
Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and current Director and former
Chair of the Children's Hospital Colorado Board of Directors; William Freytag, PhD, former Chairman and CEO
of Myogen, Inc.; James C. T. Linfield, Partner‐in‐Charge of the Colorado office Cooley LLP; and David Perez,
President and Chief Executive Officer of CaridianBCT, becoming TerumoBCT. These new directors are actively
involved the bioscience community ‐ locally, nationally and internationally ‐ and maintain those critical
relationships with entrepreneurs, companies and research groups required to guide the FRA through its next
phase of growth.
Just last week, the Aurora City Council announced three appointments to the FRA Board, including newly
elected Mayor Steve Hogan and Councilwomen Melissa Miller and Marsha Berzins.
According to Elliman, quoted recently in the Denver Post: "The land north of Montview on the Fitzsimons
property represents one of the great economic‐development opportunities in Colorado, maybe the greatest in
the state." Visit: http://www.denverpost.com/search/ci_18108184.
Further, as Brown said in Denver Business Journal news coverage last month, the expansion "should handle
the expected 10 to 12 CU spinoffs coming out of the university each year." Adding, "What we’re not seeing is
relocating to the site by more mature companies...the board is doubling down and looking into what’s
preventing it.” Visit http://www.bizjournals.com/denver/news/2011/11/15/fitzsimons‐authority‐names‐4‐
board.html.
As background, in 1996, the City of Aurora and University of Colorado worked together to create a special‐
purpose governmental entity, giving it a single mission: to imagine and govern the evolution of a historic army
medical center into one of the world’s most forward‐looking bioscience districts. In partnership with the
University of Colorado and the City of Aurora, the FRA acquired much of the former army site and began to
implement an ambitious redevelopment plan that now comprises the growing and thriving Fitzsimons Life
Science District that includes the Colorado Science + Technology Park now adjacent to the Anschutz Medical
Campus and the new V.A. hospital campus.
"As the Fitzsimons site has matured, it's become clear to the FRA board that it needed to do more to support
the growth of early‐stage Colorado bioscience companies, especially those developing technologies from
Colorado's research institutions, with an emphasis on those technologies developed at the Anschutz Medical
Campus. Accordingly, the FRA is now addressing the critical need to provide space for maturing bioscience
companies with its accelerator expansion, as well as bringing bioscience‐focused leadership to the board
process in building new corporate partnerships and leveraging the strength of the Anschutz Medical Campus
and the FRA's real estate development partner, the Forest City Science + Technology Group," Brown explains.
About the Colorado Science + Technology Park
The Colorado Science + Technology Park is the center of The Fitzsimons Life Science District, one of the nation’s largest
bioscience developments and the heart of Colorado's bioscience community. As the development partner with the
Fitzsimons Redevelopment Authority, Forest City Fitzsimons, Inc., offers a full range of purchase, lease and build‐to‐suit
opportunities for world‐class research, resources and facilities in a 184‐acre, walkable environment featuring open space
and other amenities designed to enhance the quality of life for employers and their employees.
‐More‐

3. Page 3
About Fitzsimons Redevelopment Authority
The FRA directs the commercial developments in the Fitzsimons Life Science District, along with its partner, Forest City
Science + Technology Group. In this role, the FRA is dedicated to providing life science companies: an environment
where they can thrive; success‐enhancing resources like the District’s incubator facilities; and services that help form
connections between private industry and the University of Colorado. Aurora’s Fitzsimons Life Science District is
becoming what its founders envisioned: a functioning community that directly supports the health and well‐being of life
science companies. For more information, visit: http://www.fitzscience.com.
# # #
Contacts:
Vicki Jenings, CPM, Director of Business Relations, Fitzsimons Redevelopment Authority ‐
http://www.fitzscience.com ‐ 720‐859‐4108 ‐ vjenings@colobio.com
Maggie Chamberlin Holben, APR, Principal ‐ Absolutely Public Relations ‐ http://www.absolutelypr.com ‐
303‐984‐9801 and 303‐669‐3558 (cell), maggie@absolutelypr.com